DK151797C - Analogifremgangsmaade til fremstilling af terbutalinderivater eller terapeutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af terbutalinderivater eller terapeutisk acceptable salte deraf

Info

Publication number
DK151797C
DK151797C DK300681A DK300681A DK151797C DK 151797 C DK151797 C DK 151797C DK 300681 A DK300681 A DK 300681A DK 300681 A DK300681 A DK 300681A DK 151797 C DK151797 C DK 151797C
Authority
DK
Denmark
Prior art keywords
terbutalin
analogue
derivatives
preparation
acceptable salts
Prior art date
Application number
DK300681A
Other languages
Danish (da)
English (en)
Other versions
DK300681A (da
DK151797B (da
Inventor
Otto Agne Torsten Olsson
Leif Aake Svensson
Kjell Ingvar Leopold Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of DK300681A publication Critical patent/DK300681A/da
Priority to DK135885A priority Critical patent/DK135885A/da
Publication of DK151797B publication Critical patent/DK151797B/da
Application granted granted Critical
Publication of DK151797C publication Critical patent/DK151797C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK300681A 1980-07-09 1981-07-07 Analogifremgangsmaade til fremstilling af terbutalinderivater eller terapeutisk acceptable salte deraf DK151797C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK135885A DK135885A (da) 1980-07-09 1985-03-26 Mellemprodukt egnet til anvendelse ved fremstilling af terbutalinderivater

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8022440 1980-07-09
GB8022440 1980-07-09
GB8116440 1981-05-29
GB8116440 1981-05-29

Publications (3)

Publication Number Publication Date
DK300681A DK300681A (da) 1982-01-10
DK151797B DK151797B (da) 1988-01-04
DK151797C true DK151797C (da) 1988-06-06

Family

ID=26276163

Family Applications (1)

Application Number Title Priority Date Filing Date
DK300681A DK151797C (da) 1980-07-09 1981-07-07 Analogifremgangsmaade til fremstilling af terbutalinderivater eller terapeutisk acceptable salte deraf

Country Status (26)

Country Link
US (1) US4442300A (es)
EP (1) EP0046144B1 (es)
KR (1) KR850000800B1 (es)
AU (1) AU542776B2 (es)
CA (1) CA1210021A (es)
CS (3) CS221847B2 (es)
CY (1) CY1271A (es)
DD (1) DD202002A5 (es)
DE (1) DE3163114D1 (es)
DK (1) DK151797C (es)
ES (3) ES503767A0 (es)
FI (1) FI812159L (es)
GR (1) GR74330B (es)
HK (1) HK93184A (es)
HU (1) HU183511B (es)
IE (1) IE51372B1 (es)
IS (1) IS1263B6 (es)
MY (1) MY8700201A (es)
NO (2) NO150153C (es)
NZ (1) NZ197627A (es)
PH (2) PH16929A (es)
PL (3) PL128584B1 (es)
PT (1) PT73335B (es)
SG (1) SG65684G (es)
SU (3) SU1128831A3 (es)
YU (3) YU170381A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8615995D0 (en) * 1986-07-01 1986-08-06 Glaxo Group Ltd Veterinary preparations
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE335359B (es) * 1966-10-19 1971-05-24 Draco Ab
GB1298771A (en) * 1969-04-01 1972-12-06 Sterling Drug Inc Carboxylic esters of hydroxyphenylalkanolamines
US4035405A (en) * 1976-07-09 1977-07-12 Interx Research Corporation Novel synthesis for preparing the hydrochloride salt of selected catecholamine derivatives
US4145441A (en) * 1977-11-04 1979-03-20 Interx Research Corporation Sympathomimetic amines exhibiting anti-hemorrhoidal activity

Also Published As

Publication number Publication date
ES8304532A1 (es) 1983-03-01
YU86683A (en) 1983-12-31
PL128517B1 (en) 1984-02-29
EP0046144B1 (en) 1984-04-11
NZ197627A (en) 1985-07-31
PT73335B (en) 1983-09-01
KR830006178A (ko) 1983-09-20
DK300681A (da) 1982-01-10
YU86583A (en) 1983-12-31
PL232109A1 (es) 1982-08-02
EP0046144A1 (en) 1982-02-17
NO150153B (no) 1984-05-21
SU1205758A3 (ru) 1986-01-15
SU1128831A3 (ru) 1984-12-07
ES512921A0 (es) 1983-03-01
MY8700201A (en) 1987-12-31
ES8300675A1 (es) 1982-11-01
PL235909A1 (es) 1982-10-25
NO151962B (no) 1985-04-01
SG65684G (en) 1985-03-15
NO812312L (no) 1982-01-11
PL128584B1 (en) 1984-02-29
IE811521L (en) 1982-01-09
ES503767A0 (es) 1982-11-01
NO150153C (no) 1984-08-29
SU1205759A3 (ru) 1986-01-15
NO151962C (no) 1985-07-10
PH16929A (en) 1984-04-17
PL128583B1 (en) 1984-02-29
CY1271A (en) 1985-03-08
DE3163114D1 (en) 1984-05-17
ES8305304A1 (es) 1983-04-01
KR850000800B1 (ko) 1985-06-14
GR74330B (es) 1984-06-25
NO833321L (no) 1982-01-11
HU183511B (en) 1984-05-28
IE51372B1 (en) 1986-12-10
PL235908A1 (es) 1982-10-25
YU170381A (en) 1983-12-31
CS221848B2 (en) 1983-04-29
AU542776B2 (en) 1985-03-14
DK151797B (da) 1988-01-04
US4442300A (en) 1984-04-10
HK93184A (en) 1984-12-07
IS2658A7 (is) 1982-01-10
CS221847B2 (en) 1983-04-29
ES512920A0 (es) 1983-04-01
FI812159L (fi) 1982-01-10
DD202002A5 (de) 1983-08-24
IS1263B6 (is) 1987-03-27
PT73335A (en) 1981-08-01
AU7262981A (en) 1982-01-14
PH17597A (en) 1984-10-02
CA1210021A (en) 1986-08-19
CS221846B2 (en) 1983-04-29

Similar Documents

Publication Publication Date Title
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK163244C (da) Analogifremgangsmaade til fremstilling af 7-oe2-(2-aminothiazol-4-yl)-2-oxyimino-acetamidoaa-ceph-3-em-4-carboxylsyrederivater eller fysiologisk acceptable salte deraf
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK152495C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf
DK163359C (da) Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK158269C (da) Analogifremgangsmaade til fremstilling af morpholinyldaunorubicin- eller morpholinyldoxorubicinderivater
DK162444C (da) Analogifremgangsmaade til fremstilling af azabicyklooctancarboxylsyrer og farmaceutisk acceptable salte heraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK149610C (da) Analogifremgangsmaade til fremstilling af trh-analoge di- eller tripeptidamider eller terapeutisk acceptable komplekser eller salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK162166C (da) Analogifremgangsmaade til fremstilling af (2s)-isomere af 2-oe4-(2-hydroxycyclopentan-1-ylmethyl)phenylaapropionsyre eller farmaceutisk acceptable salte deraf
DK158306C (da) Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf
DK156252C (da) Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK149269C (da) Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK149611C (da) Analogifremgangsmaade til fremstilling af trh-analoge tripeptidamider eller terapeutisk acceptable komplexer eller salte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed